The specialty chemist Arxada plans to invest 20 million francs to strengthen its infrastructure in Visp. This decision is part of the extension of a long-term collaboration with Dutch Royal DSM, active in the fields of health, nutrition and materials.
Niacin production
This investment should be used to extend the production lines in Visp and thus enable Arxada to meet the demand for a greater supply of niacin (vitamin B3) and other ingredients intended for the nutrition of Royal DSM which is in the process of bringing together the flavors and fragrances giant Firmenich.
behind, former division of biochemist Lonzaalso plans to devote funds to reducing its carbon dioxide (CO2) emissions from the Visp site, so as to bring it into line with the commitments of the two companies.
